Physician profile
Lauren Coe
NPI 1659729218
$3,472.47
in general payments reported to CMS, 2019-2025
11 companies · $20.00 in 2025
The $20.00 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,338 · 2020: $46.73 · 2021: $1,319 · 2022: $262 · 2023: $319 · 2024: $167 · 2025: $20.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $506.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,632.59 | 2019-2022 | |
| Orthofix Medical, INC. | $1,065.58 | 2019 | |
| Smith+Nephew, INC. | $299.57 | 2020-2024 | Grafix Pl, Grafix |
| Organogenesis INC. | $148.10 | 2023 | Puraply |
| Stryker Corporation | $140.28 | 2021-2022 | |
| Paragon 28, INC. | $43.17 | 2019-2021 | |
| Paratek Pharmaceuticals, INC. | $42.77 | 2020-2021 | |
| Medtronic, INC. | $31.53 | 2024 | Intellis Adaptivestim |
| Gemini Mountain Medical, LLC | $26.54 | 2023 | |
| Kci USA, INC. | $22.34 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $20.00 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Coe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.